ADAR and hnRNPC deficiency synergize in activating endogenous dsRNA-induced type I IFN responses

Author:

Herzner Anna-Maria1ORCID,Khan Zia2ORCID,Van Nostrand Eric L.3ORCID,Chan Sara4ORCID,Cuellar Trinna5ORCID,Chen Ronald2ORCID,Pechuan-Jorge Ximo1ORCID,Komuves Laszlo4ORCID,Solon Margaret4ORCID,Modrusan Zora6,Haley Benjamin5ORCID,Yeo Gene W.3ORCID,Behrens Timothy W.2ORCID,Albert Matthew L.1ORCID

Affiliation:

1. Department of Cancer Immunology, Genentech, South San Francisco, CA

2. Department of Human Genetics, Genentech, South San Francisco, CA

3. Department of Cellular and Molecular Medicine, Stem Cell Program and the Institute for Genomic Medicine, University of California, San Diego, La Jolla, CA

4. Department of Pathology, Genentech, South San Francisco, CA

5. Department of Molecular Biology, Genentech, South San Francisco, CA

6. Department of Microchemistry, Proteomics & Lipidomics and Next Generation Sequencing, Genentech, South San Francisco, CA

Abstract

Cytosolic double-stranded RNA (dsRNA) initiates type I IFN responses. Endogenous retroelements, notably Alu elements, constitute a source of dsRNA. Adenosine-to-inosine (A-to-I) editing by ADAR induces mismatches in dsRNA and prevents recognition by MDA5 and autoinflammation. To identify additional endogenous dsRNA checkpoints, we conducted a candidate screen in THP-1 monocytes and found that hnRNPC and ADAR deficiency resulted in synergistic induction of MDA5-dependent IFN responses. RNA-seq analysis demonstrated dysregulation of Alu-containing introns in hnRNPC-deficient cells via utilization of unmasked cryptic splice sites, including introns containing ADAR-dependent A-to-I editing clusters. These putative MDA5 ligands showed reduced editing in the absence of ADAR, providing a plausible mechanism for the combined effects of hnRNPC and ADAR. This study contributes to our understanding of the control of repetitive element–induced autoinflammation and suggests that patients with hnRNPC-mutated tumors might maximally benefit from ADAR inhibition-based immunotherapy.

Funder

National Human Genome Research Institute

Damon Runyon Cancer Research Foundation

Publisher

Rockefeller University Press

Subject

Immunology,Immunology and Allergy

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3